title: Primary non-Hodgkin's lymphoma of the vagina.
authors.forename: F
authors.initials: F
authors.lastname: Raspagliesi
authors.forename: A
authors.initials: A
authors.lastname: Ditto
authors.forename: R
authors.initials: R
authors.lastname: Fontanelli
authors.forename: G
authors.initials: G
authors.lastname: Gallino
authors.forename: P B
authors.initials: PB
authors.lastname: Massone
authors.forename: G
authors.initials: G
authors.lastname: De Palo
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011247:Pregnancy; D011256:Pregnancy Outcome; D014625:Vaginal Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D008727:Methotrexate